These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29885096)

  • 1. Scale-dependent manganese leaching from stainless steel impacts terminal galactosylation in monoclonal antibodies.
    Williamson J; Miller J; McLaughlin J; Combs R; Chu C
    Biotechnol Prog; 2018 Sep; 34(5):1290-1297. PubMed ID: 29885096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose.
    Gramer MJ; Eckblad JJ; Donahue R; Brown J; Shultz C; Vickerman K; Priem P; van den Bremer ET; Gerritsen J; van Berkel PH
    Biotechnol Bioeng; 2011 Jul; 108(7):1591-602. PubMed ID: 21328321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHO cell line specific prediction and control of recombinant monoclonal antibody N-glycosylation.
    Grainger RK; James DC
    Biotechnol Bioeng; 2013 Nov; 110(11):2970-83. PubMed ID: 23737295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling the time evolution of mAb N-linked glycosylation, Part I: Microbioreactor experiments.
    Villiger TK; Roulet A; Périlleux A; Stettler M; Broly H; Morbidelli M; Soos M
    Biotechnol Prog; 2016 Sep; 32(5):1123-1134. PubMed ID: 27254475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traces matter: Targeted optimization of monoclonal antibody N-glycosylation based on/by implementing automated high-throughput trace element screening.
    Markert S; Torkler S; Hohmann K; Popp O
    Biotechnol Prog; 2020 Nov; 36(6):e3042. PubMed ID: 32583628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of orbitally-shaken and stirred-tank bioreactors: pH modulation and bioreactor type affect CHO cell growth and protein glycosylation.
    Monteil DT; Juvet V; Paz J; Moniatte M; Baldi L; Hacker DL; Wurm FM
    Biotechnol Prog; 2016 Sep; 32(5):1174-1180. PubMed ID: 27453130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of media and antifoam selection on monoclonal antibody production and quality using a high throughput micro-bioreactor system.
    Velugula-Yellela SR; Williams A; Trunfio N; Hsu CJ; Chavez B; Yoon S; Agarabi C
    Biotechnol Prog; 2018 Jan; 34(1):262-270. PubMed ID: 29086492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Process-relevant concentrations of the leachable bDtBPP impact negatively on CHO cell production characteristics.
    Kelly PS; McSweeney S; Coleman O; Carillo S; Henry M; Chandran D; Kellett A; Bones J; Clynes M; Meleady P; Barron N
    Biotechnol Prog; 2016 Nov; 32(6):1547-1558. PubMed ID: 27557043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Tubespins as a suitable scale-down model of bioreactors for high cell density CHO cell culture.
    Gomez N; Ambhaikar M; Zhang L; Huang CJ; Barkhordarian H; Lull J; Gutierrez C
    Biotechnol Prog; 2017 Mar; 33(2):490-499. PubMed ID: 27977914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time monitoring of antibody glycosylation site occupancy by in situ Raman spectroscopy during bioreactor CHO cell cultures.
    Li MY; Ebel B; Paris C; Chauchard F; Guedon E; Marc A
    Biotechnol Prog; 2018 Mar; 34(2):486-493. PubMed ID: 29314747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation and modeling of monoclonal antibody N-linked glycosylation in mammalian cell perfusion reactors.
    Karst DJ; Scibona E; Serra E; Bielser JM; Souquet J; Stettler M; Broly H; Soos M; Morbidelli M; Villiger TK
    Biotechnol Bioeng; 2017 Sep; 114(9):1978-1990. PubMed ID: 28409838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying a robust design space for glycosylation during monoclonal antibody production.
    St Amand MM; Hayes J; Radhakrishnan D; Fernandez J; Meyer B; Robinson AS; Ogunnaike BA
    Biotechnol Prog; 2016 Sep; 32(5):1149-1162. PubMed ID: 27273898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Process development for an inducible rituximab-expressing Chinese hamster ovary cell line.
    Mellahi K; Cambay F; Brochu D; Gilbert M; Perrier M; Ansorge S; Durocher Y; Henry O
    Biotechnol Prog; 2019 Jan; 35(1):e2742. PubMed ID: 30414355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling the time evolution of mAb N-linked glycosylation - Part II: Model-based predictions.
    Villiger TK; Scibona E; Stettler M; Broly H; Morbidelli M; Soos M
    Biotechnol Prog; 2016 Sep; 32(5):1135-1148. PubMed ID: 27273889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A system identification approach for developing model predictive controllers of antibody quality attributes in cell culture processes.
    Downey B; Schmitt J; Beller J; Russell B; Quach A; Hermann E; Lyon D; Breit J
    Biotechnol Prog; 2017 Nov; 33(6):1647-1661. PubMed ID: 28786215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of heavy chain C-terminal deletions on productivity and product quality of monoclonal antibodies in Chinese hamster ovary (CHO) cells.
    Hu Z; Tang D; Misaghi S; Jiang G; Yu C; Yim M; Shaw D; Snedecor B; Laird MW; Shen A
    Biotechnol Prog; 2017 May; 33(3):786-794. PubMed ID: 28188688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ambient light on monoclonal antibody product quality during small-scale mammalian cell culture process in clear glass bioreactors.
    Mallaney M; Wang SH; Sreedhara A
    Biotechnol Prog; 2014; 30(3):562-70. PubMed ID: 24777986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioreactor scale up and protein product quality characterization of piggyBac transposon derived CHO pools.
    Rajendra Y; Balasubramanian S; Peery RB; Swartling JR; McCracken NA; Norris DL; Frye CC; Barnard GC
    Biotechnol Prog; 2017 Mar; 33(2):534-540. PubMed ID: 28188692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down study of the effect of harvesting by centrifugation on the post-translational modification profile.
    Reid CQ; Tait A; Baldascini H; Mohindra A; Racher A; Bilsborough S; Smales CM; Hoare M
    Biotechnol Bioeng; 2010 Sep; 107(1):85-95. PubMed ID: 20506289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioreactor as the root cause of the "manganese effect" during
    Fekete E; Bíró V; Márton A; Bakondi-Kovács I; Németh Z; Sándor E; Kovács B; Fábián I; Kubicek CP; Tsang A; Karaffa L
    Front Bioeng Biotechnol; 2022; 10():935902. PubMed ID: 35992333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.